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Abstract: Many suggested policy interventions for childhood and adolescent obesity have costs 11 
and effects that fall outside the health care sector. These cross-sectorial costs and consequences 12 
have implications for how economic evaluation is applied and although previous systematic 13 
reviews have provided a summary of cost-effectiveness, very few have conducted a review of 14 
methods applied. We undertook this comprehensive review of economic evaluations, appraising 15 
the methods used, assessing the quality of the economic evaluations and summarising 16 
cost-effectiveness. Nine electronic databases were searched for full-economic evaluation studies 17 
published between January 2001 and April 2017 with no language or country restrictions. 39 18 
economic evaluation studies were reviewed and quality assessed. Almost all the studies were from 19 
Western countries and methods were found to vary by country, setting and type of intervention. 20 
The majority, particularly “behavioural and policy” preventive interventions, were cost-effective, 21 
even cost-saving. Only four interventions were not cost effective. This systematic review suggests 22 
that economic evaluation of obesity interventions is an expanding area of research. However, 23 
methodological heterogeneity makes evidence synthesis challenging. Whilst upstream 24 
interventions show promise, an expanded and consistent approach to evaluate cost-effectiveness is 25 
needed to capture health and non-health costs and consequences. 26 
Keywords: cost effectiveness; methods; children; adolescents; obesity; prevention; treatment 27 
 28 
1. Introduction 29 
Childhood obesity is a major global public health problem with associated health, social and 30 
emotional consequences, as well as long term direct and indirect costs [1-4]. Effective obesity 31 
prevention and treatment in children and adolescents is therefore a priority as it is far more 32 
cost-effective to prevent the onset of obesity in childhood compared to a lifetime of 33 
obesity-associated costs. However, despite an increasing number of intervention studies, there are 34 
relatively few published economic evaluations [5-7]. 35 
In many countries, the scarcity of public resources requires decision makers to seek information 36 
on cost-effectiveness as well as clinical effectiveness in the knowledge that the use of resources in 37 
one way prevents their use in others [8]. Economic evaluation is a means to aid decisions about 38 
public resource allocation [9, 10] and as obesity prevention and treatment often involves lifestyle 39 
interventions that have costs and consequences that fall outside the health care sector, a societal 40 
perspective for evaluation is usually recommended [10]. This means that all relevant resource 41 
use/costs and consequences are measured, outlining how these fit within a given sector, such as 42 
health, education or the wider community [11]. However, when incorporating costs and outcomes 43 
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that span across multiple sectors, it is not always clear how much society is willing to pay for a 44 
‘non-health’ effect caused by an intervention funded from a ‘health care budget’. Also, the valuation 45 
of resources for which no market exists, such as informal care, or patient time costs, requires specific 46 
methods [8]. 47 
Seven recent reviews [12-18] have summarised the cost-effectiveness of obesity prevention 48 
and/or treatment interventions in young people however none were designed to offer a rigorous 49 
review of methods applied for economic evaluation. Five reviews had language restrictions [12-15, 50 
17] and four excluded studies that were conducted in developing countries [12, 13, 15, 17], limiting 51 
global interpretation. Only two reviews appraised methods for handling inter-sectoral costs [13, 17]. 52 
Just three of the reviews used established criteria e.g. Drummond checklist [19] to assess the quality 53 
of the primary studies [13, 14, 17]. The search strategy was inadequate (e.g. search terms not fully 54 
reported) in three reviews [12, 15, 20], and in the remaining four there were omissions of relevant 55 
databases, which means that relevant studies could have been missed [13, 14, 16, 17]. Furthermore, 56 
the most recent review, which only focused on interventions in pre-school children, included studies 57 
reported up to November 2015 and, at least 3 new economic evaluation studies of childhood obesity 58 
interventions have been published since then [21-23].  59 
This paper reports on a systematic review of published economic evaluations of obesity 60 
prevention and/or treatment interventions in children and adolescents (0-19 years) with the primary 61 
objective of appraising the methods used and assessing the quality of the economic evaluations 62 
using the Drummond checklist [19]. A secondary objective was to undertake a narrative synthesis of 63 
the evidence of the cost-effectiveness.  64 
2. Materials and Methods 65 
The systematic review follows the reporting guidelines of Preferred Reporting Items for 66 
Systematic Reviews and Meta-Analyses (PRISMA) [24] and a completed PRISMA checklist is 67 
presented in Section A (see Supplementary Material). The protocol is registered with the 68 
international prospective register of systematic reviews (PROSPERO) database ref 69 
(CRD42017062236) and has previously been published [25]. 70 
2.1. Literature Search 71 
The following electronic health economics/biomedical databases were searched: MEDLINE 72 
(Ovid); EMBASE (Ovid); Web of Science; CINAHL Plus; EconLit; PsycINFO; Cochrane Database of 73 
Systematic Reviews (CDSR); Database of Abstracts of Reviews of Effects (DARE); the National 74 
Health Service Economic Evaluation Database (NHS EED); Health Technology Assessment (HTA) 75 
and Cost-Effectiveness Analysis (CEA) Registry. The following sources were also used to identify 76 
potential additional studies: Google Scholar; relevant National Institute for Health and Care 77 
Excellence (NICE) guidelines; the reference lists of eligible studies and review articles; and Grey 78 
literature such as OpenSIGLE, National Obesity Observatory, NHS Evidence, National Technical 79 
Information Service, Healthcare Management Information Consortium (HMIC) and RePEC 80 
(Economic Working papers) database. The search was conducted in May 2017 and studies were 81 
sought between January 2001 and April 2017. The year 2001 was chosen since the first study 82 
evaluating the cost-effectiveness of a childhood obesity treatment intervention was published then 83 
followed 2 years later by the first economic evaluation of a childhood obesity prevention 84 
intervention [16]. Search strategies included Medical Subject Headings (MeSH) terms and text words 85 
of key papers that were identified beforehand. The search terms and text words were adapted for 86 
use within other bibliographic databases. The full search strategy is presented in Section B (see 87 
Supplementary Material). 88 
2.2. Inclusion and Exclusion Criteria 89 
Economic evaluations were included or excluded based on the following criteria: 90 
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Types of study: Primary full economic evaluations were included (studies in which both the 91 
costs and outcomes of the alternatives are examined and in which a comparison of two or more 92 
interventions or case alternatives are undertaken) including trial-based and model-based (using trial 93 
data) evaluations. Partial economic evaluations; qualitative studies; conference abstracts; and study 94 
protocols were excluded. 95 
Participants/ population: Children and adolescents aged 0-19 years at the start of the 96 
intervention and/or their parents/guardians were included. Family based interventions were also 97 
included when the target participants were the children. Economic evaluations undertaken within 98 
any country context were included. Interventions to tackle obesity due to a secondary cause (e.g. 99 
Prader-Willi syndrome) were excluded. 100 
Intervention(s), exposure(s): All behavioural (focused on individual behaviour change 101 
techniques), environmental (focused on modifying the local environment) or policy (focused on 102 
population-wide legislative or fiscal action) interventions for the treatment or prevention of 103 
overweight/obesity in children and/or adolescents were included. Pharmacological or surgical 104 
interventions were excluded. 105 
Comparator(s)/control: Only studies with a clearly defined comparator were included with no 106 
restrictions on the types of comparator(s).  107 
Outcome(s): No restrictions on outcomes measures. Potentially relevant outcomes were: 108 
Disability Adjusted Life Years (DALYs); Quality Adjusted Life Years (QALYs); effectiveness 109 
outcomes such as kilogramme weight loss; % Body Fat; Body Mass Index (BMI) z-score; waist 110 
circumference; overweight and obesity cases avoided; additional minute of Moderate to Vigorous 111 
Physical Activity (MVPA); increase in overall physical activity level and Metabolic Equivalent 112 
(MET) hour gained.  113 
Other criteria: There were no restrictions based on language. 114 
2.3. Study Selection Procedure 115 
The review followed a two-stage method. First, the main researcher and an independent 116 
researcher individually screened titles and abstracts of identified publications against the selection 117 
criteria. If in doubt, the full text version was requested. Second, full-text papers were reviewed by 118 
both researchers and a final decision made with respect to the inclusion/exclusion criteria. There was 119 
85% agreement between the 2 reviewers. Any disagreements between the reviewers over the 120 
eligibility of specific studies were resolved by discussion between all authors. To aid study selection 121 
and analysis of non-English language articles, translation either in part or in whole was undertaken 122 
by academic colleagues with the appropriate language skills. The literature search results were 123 
managed using Endnote 7 (Thomson Reuters). 124 
2.4. Data Extraction 125 
The study characteristics and findings were recorded using a standardised, pre-piloted data 126 
extraction form (see Tables S1 (i) – S1 (iv) and Tables S2-4 (i) – S2-4 (iv) in Supplementary Material). 127 
This process was checked for completeness and accuracy by an independent researcher. Any 128 
discrepancies between the reviewers over the data extraction process was identified and resolved by 129 
discussion or by consensus with all authors. 130 
2.5. Quality Assessment of Included Studies 131 
The quality of the economic evaluations were judged against standard criteria (Drummond 132 
checklist) [19], see Table S5 (see Supplementary Material). Quality assessment of the included 133 
studies was independently checked for completeness and accuracy by an independent researcher 134 
and any discrepancies were resolved by discussion with all authors. 135 
3. Results 136 
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From the 4,185 references initially identified, 39 economic evaluations were included – see 137 
Figure 1. The most common reasons for exclusion were the lack of (full) economic evaluations, being 138 
a protocol study, or including an ineligible target population. 139 
 140 
Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow 141 
diagram. 142 
3.1. Details about Study Context 143 
Full details about study context are presented in Tables S1 (i) – S1 (iv) (see Supplementary 144 
Material), and summarised in Table 1.  145 
Table 1. Summary of general characteristics of the studies. 146 
Study characteristics Number of studies identified (%)  
Year of publication 
2001-2009 17 (44)  
2010-2017 22 (56)  
Study approach 
Trial-based  
Prevention 9 (23)  
Treatment 7 (18) 
 
 
Model-based Prevention 19 (49)  
Treatment 4 (10)  
Comparator selected 
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Usual care 33 (85)  
Another intervention 6 (15)  
Country 
High-income 
Australia 
New Zealand 
The USA 
Canada 
The UK 
 
15 (38.5) 
2 (5) 
12 (31.5) 
1 (2.5) 
4 (10) 
 
Germany 2 (5)  
Finland 1 (2.5)  
Spain 
Low and middle-income 
China 
1 (2.5) 
 
1 (2.5) 
 
Setting 
School Prevention 
US/Australian state 
21 (54) 
5 (13) 
 
Community 1 (2.5)  
Home 
Clinical Treatment  
1 (2.5) 
9 (23)  
School 
Community 
1 (2.5) 
1 (2.5) 
 
3.1.1. Intervention and Comparator 147 
Approximately half of the economic evaluations (23/39) were model-based [12, 23, 26-41] 148 
compared to trial-based evaluations. A range of interventions were identified, all containing 149 
individual behaviour change elements (Figure 2). A large proportion (25/39) (including all treatment 150 
interventions) were focused exclusively on behaviour change techniques, the rest combined 151 
individual behaviour change elements with either an environmental component (modifying the 152 
local environment e.g. active school transport) [22, 30-34, 42, 43] or a policy component 153 
(population-wide legislative or fiscal interventions such as banning unhealthy food advertising or a 154 
physical education policy) [26, 28, 29, 36, 39, 44]. Approximately half of the interventions (21/39; 12 155 
prevention and 9 treatment) targeted a combination of physical activity and dietary behaviours [12, 156 
21, 27, 33, 37-43, 45-51], the rest focused on either physical activity [22, 26, 30-32, 34, 44, 52-54] or 157 
dietary habits only [12, 23, 28, 29, 36, 55].  158 
 159 
Figure 2. Summary of the interventions. 160 
The intensity of the interventions differed considerably. For prevention interventions, this 161 
ranged from one session per 3 months [45] to approximately 2 sessions per month [52]; and for 162 
treatment interventions, ranged from one [21] to 12 sessions per week [47]. The duration of the 163 
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interventions also differed, ranging from 8 months [54] to 4 years [53] for prevention studies; and 164 
from 3 months [21] to 1 year [47] for treatment studies. Overall therefore, the treatment interventions 165 
were generally more intensive but delivered over a shorter time period compared to prevention 166 
interventions. The comparison or control group was not always clearly specified but was assumed to 167 
be “usual care” in most of the studies (33/39) and often the studies did not justify their rationale for 168 
choosing the comparator. 169 
3.1.2. Country and Setting 170 
The evaluations were spread across a wide range of countries and study settings. The vast 171 
majority (38/39) originated from high-income countries, mainly Australasia (Australia (n=15) [12, 22, 172 
29-33, 41, 45, 51] and New Zealand (n=2) [35, 42]), with 13 from North America (USA (n=12) [23, 173 
26-28, 36-39, 43, 44, 47, 50], Canada (n=1) [48]) and 8 from Europe (UK (n=4) [21, 34, 40, 49], Germany 174 
(n=2) [52, 53], Finland (n=1) [55], Spain (n=1) [54]). Only one study was from a developing country 175 
context - China [46]. In terms of study setting, the majority of prevention interventions (21/28) were 176 
school-based [22, 23, 27, 30-33, 35, 37, 38, 42, 43, 46, 50, 52-54] and for treatment interventions, most 177 
(9/11) took place in clinical settings [12, 21, 40, 41, 47-49, 51, 55]. 178 
3.2. Review of Economic Evaluation Methods  179 
A detailed account of the economic evaluation methods are presented in Tables S2-4 (i) – S2-4 180 
(iv) (see Supplementary Material). 181 
3.2.1. Type of Economic Evaluation and Measures of Effectiveness 182 
The majority of studies that conducted a Cost-Effectiveness Analysis (CEA) used raw or 183 
standardised BMI as a measure of clinical outcome (26/39) (18 prevention and 8 treatment), whilst 184 
other studies used one or more measures from: cases of overweight/obesity prevented; unit increase 185 
in MET minutes; reduction in body fat or waist circumference. Approximately half of the studies 186 
that undertook a CEA also conducted a Cost-Utility Analysis (CUA) [21, 28-34, 36, 41] with QALYs 187 
as the primary outcome measure. The review found that the vast majority of trial-based economic 188 
evaluations (15/16) did not use QALYs/DALYs whereas most model-based evaluations (n=20) 189 
tended to report QALYs/DALYs as the primary economic outcome. When QALYs were used, the 190 
age of the participants was between 6 and 11 years in the trial-based economic evaluation [21], and 191 
between 2 and 19 years in the model-based economic evaluations.  192 
A pattern with preferred type of economic evaluation by country context was apparent. Within 193 
Australasia (13/17) a CUA or a combination of CUA and CEA [12, 29-33, 35, 41] was most popular, 194 
whereas the majority of studies from North America (7/13) [26, 39, 43, 44, 47, 48, 50], and the only 195 
study from China [46] conducted a CEA only. Across Europe, only UK-based studies used CUA [21, 196 
34]. In terms of study setting, a CEA was most common in clinical settings (7/9), whereas within 197 
school settings a mixed approach was applied with around half conducting a CEA (12/22).  There 198 
was no clear pattern found in terms of approach taken to evaluate prevention or treatment 199 
interventions.  200 
3.2.2. Evaluation Perspective Taken 201 
Most (35/39) studies clearly reported the study perspective. The majority (n=29) were from a 202 
societal perspective. Interestingly, none of the UK studies [21, 34, 40, 49], compared to most of those 203 
conducted within Australia and the USA, applied a societal perspective. Two studies reported using 204 
a health care perspective, but from the data reported it was clear that wider societal costs were 205 
included within a secondary analysis [21, 51].  206 
For all interventions that included either a policy or environmental component (12/14), the 207 
perspective was societal, whereas for interventions focused exclusively on individual behaviour 208 
change a combination of societal (17/25) and healthcare (6/25) perspectives was undertaken. A 209 
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societal perspective was also adopted by the vast majority of interventions implemented in school 210 
settings (19/22). 211 
3.2.3. Time Horizon Considered and Type of Modelling Approach Taken 212 
The time durations for the trial-based economic evaluations were predicted by the period of the 213 
trial.   Of interest this ranged from 8 months [54] to 6 years [53] in the prevention studies; and from 214 
10 months [50] to 15 months [51] for the treatment interventions. For the model-based evaluations, 215 
the time horizon was more at the analysts discretion and within this review ranged from at least 10 216 
years (n=5) [26, 28, 36, 38, 39] to a lifetime (15/23) [12, 23, 29-33, 35, 40, 41]. The time horizon was also 217 
found to be much shorter within clinical settings (6/9) [21, 47-49, 51, 55] compared to the other study 218 
settings such as schools for example. The majority of the studies did not justify their choice of time 219 
horizon.  220 
With respect to modelling, the vast majority of model-based studies (18/23) applied Markov 221 
modelling [12, 26, 28-33, 35, 36, 39-41] compared to decision analytic modelling [23, 27, 34, 37, 38]. 222 
The majority of the model-based studies did not justify their model choice and the description of 223 
model details was suboptimal in most of them. 224 
3.2.4. Choice of Discount Rate 225 
For the majority of the trial-based studies (10/16) (4 prevention and 6 treatment), discounting 226 
was not appropriate as the time horizons considered were relatively short (less than one year) [21, 227 
43, 46-50, 52, 54, 55]. For all the trial-based studies of more than one year, all reported using a 228 
discount rate in accordance with the relevant country guidelines apart from one prevention trial 229 
from New Zealand [42], which used a 5% discount rate per year for costs, rather than the 3.5% 230 
discount rate per year for both costs and outcomes recommended [56]. Most model-based studies 231 
(22/23) applied a discount rate for both costs and outcomes (3% per year for Australia (n=12) [12, 232 
29-33, 41], the USA (n=8) [23, 26-28, 36-39] and the UK (n=1) [40], and 3.5% per year for New Zealand 233 
(n=1) [35]. Interestingly, the rates used for studies from Australia and the UK were not in accordance 234 
with their respective country guidelines (which is 5% per year for Australia according to PBAC and 235 
3.5% per year for the UK according to NICE) [57, 58]. However, different state governments in 236 
Australia recommend different rates and the discount rate used in the included Australian and UK 237 
studies was consistent with the US panel recommendations [59]. Most of the studies did not justify 238 
their choice of discount rate. 239 
3.2.5. Methods for Collecting and Estimating Resource Use/Costs  240 
Half of the trial-based evaluations (8/16) (4 prevention and 4 treatment) reported their methods 241 
for collecting resource use [21, 22, 45, 47, 49, 51-53], while only 10 out of 23 model-based evaluations 242 
(9 prevention and 1 treatment) did so [23, 26, 28, 30-33, 36, 39, 41].  243 
As expected, the choice of inclusion of a particular type of cost varied considerably according to 244 
the study purpose, perspective, setting and the nature of the intervention being evaluated. Costs 245 
tended to be categorised into programme delivery, direct medical (e.g. healthcare visits), direct 246 
non-medical (e.g. travel time/cost for participants) and indirect (e.g. productivity losses because of 247 
parents’ absence from work). In line with recommendations for CEA [60], the development/set up 248 
costs were not considered in the vast majority of studies, apart from one trial-based prevention 249 
study from the USA [44]. 250 
Of the 9 studies (5 prevention and 4 treatment) that included indirect costs incurred by parents 251 
[21, 30, 31, 33, 41, 43, 47, 51, 53], these were mainly from Australia (n=5) and most of them were for 252 
preventive “behavioural” interventions within a school-based setting (5/9). Also, direct non-medical 253 
costs were reported by 4 prevention studies from Australia [30, 33, 41, 51] and 1 treatment study 254 
from the USA [47]. Most of these types of costs (3/5) were for “behavioural” interventions 255 
implemented within a clinical setting. 256 
3.2.6. Sensitivity Analysis Undertaken 257 
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The majority of the trial-based studies (10/16) conducted a deterministic sensitivity analysis to 258 
assess the robustness of the results [21, 22, 42, 43, 45, 51-55]. Most of the model-based studies (22/23) 259 
apart from the study by Pringle et al (2010) from the UK [34], conducted at least one type of 260 
sensitivity analysis with the majority (n=20) applying both deterministic and probabilistic sensitivity 261 
analysis in line with recommendations. Half of these studies however did not justify the choice of 262 
covariates for the sensitivity analysis. 263 
3.3. Narrative Synthesis of Cost-Effectiveness Evidence 264 
The most common method for presenting cost-effectiveness evidence was the Incremental 265 
Cost-Effectiveness Ratio (ICER) (30/39). The vast majority of the studies (33/37), excluding the CCA 266 
ones, reported results that were cost-effective. Some of these (13 of the model-based 267 
prevention/treatment studies including 5 by Carter et al (2009)), [12, 28, 29, 34, 36-40] illustrated cost 268 
saving results. For instance, Long et al (2015) concluded that a sugar-sweetened beverage excise tax 269 
would increase benefits in terms of DALYs averted and result in healthcare cost savings in the USA 270 
[28]. Almost half of these 13 studies that illustrated cost-savings were from Australia, followed by 5 271 
from the USA and 2 from the UK. None of the trial-based evaluations reported cost saving results, 272 
probably due to shorter time horizons. Whilst the findings are not directly comparable between 273 
studies due to the heterogeneous nature of the methods used, all of the studies which evaluated 274 
interventions targeting only dietary habits (8/8) and the majority of the studies targeting both 275 
physical activity and dietary habits (19/21) indicated cost-effective or cost saving results. However, 276 
the studies which focused on only physical activity indicated a proportionally smaller number of 277 
cost-effective or cost saving results (7/10). Furthermore, the evidence suggests that the majority of 278 
behavioural interventions supported by a policy intervention (4/6) were cost-saving [28, 29, 36, 39].  279 
A small number of studies (n=4) [21, 30-32] reported interventions to not be cost-effective. The 280 
UK trial-based treatment study [21], which targeted a combination of physical activity and dietary 281 
habits with the aim to reduce weight gain in children with obesity remained not cost-effective using 282 
a CEA/CUA approach regardless of the choice of perspective. Also, the 3 model-based studies that 283 
targeted only physical activity were not cost-effective, for example, the “Walking School Bus” 284 
programme which had a high cost of delivery coupled with low participation rates [30]. 285 
3.4. Quality Assessment of the Included Studies  286 
The quality of reporting the economic evaluations was assessed using the Drummond checklist. 287 
Full details of the quality assessment are presented in Tables S6 (i) – S6 (iv) (see Supplementary 288 
Material). None of the included studies fulfilled all of the quality criteria however only a small 289 
number of the studies were categorised as poor. One challenge regarding the quality assessment was 290 
that quality was judged based on the published data only and there might be a difference in what 291 
has been reported and what has actually been done. So a bad scoring study might just be due to lack 292 
of transparency rather than lack of quality.  293 
Certain criteria were simply not applicable to each respective study (e.g. items 12–15, due to 294 
different perspectives chosen), while others were not reported. The three criteria which were least 295 
well addressed were the rationale for the comparator, the justification for the choice of discount rate, 296 
and the model choice. Whilst the time horizon for each study was generally well specified, most 297 
studies omitted to provide reasons for choice. Additionally, approximately half of the studies did 298 
not justify the choice of economic evaluation nor offered justification for what was explored within a 299 
sensitivity analysis. 300 
4. Discussion 301 
To the best of our knowledge this is the first study to conduct a review of the methods for 302 
economic evaluation and to determine how these methods vary by setting, country and intervention 303 
design.  304 
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The review identified some emerging patterns. We found that among the published economic 305 
evaluations, there was no consistent measure of outcomes. Around half of the studies reported 306 
clinical (e.g. BMI), rather than health-related outcome measures commonly used within economic 307 
evaluation (QALYs/DALYs). This suggests that the measurement of QALYs/DALYs within obesity 308 
trials is not firmly established. This heterogeneity of outcome measures will hinder comparability of 309 
cost-effectiveness.  310 
No evaluation applied a Cost-Benefit Analysis (CBA) approach. Consideration of broader 311 
outcomes going beyond the health sector allows for inclusion of costs and effects from multiple 312 
sectors and is particularly relevant for obesity intervention.  This is an emerging area of 313 
development within economic evaluation and efforts are being made to adapt methodologies to 314 
promote the use of CBA [61]. These approaches have been recommended by the UK Treasury 315 
guidance to evaluate (usually non-health) public sector projects [62]. 316 
Model-based evaluations offer the opportunity to improve the generalisability of results as they 317 
combine data from a variety of sources. However the findings from five of the model-based 318 
evaluations identified within this review were based on small samples [23, 27, 34, 37, 38] and only 319 
one of these offered data based on a lifetime horizon. Furthermore, all of the model-based 320 
evaluations were for interventions that targeted individual health behaviours and were therefore 321 
highly dependent on cultural, infrastructural and other system-related aspects. So the 322 
generalisability of results to other contexts, particularly from developed to developing country 323 
settings, would be questionable [63]. The majority of the papers did not make explicit mention of 324 
procedures for checking their models and no study assessed the sensitivity of their results to the 325 
choice of model-type. Despite associated assumptions with modelling studies, the studies evaluated 326 
are important as model-based health economic evaluations are today widely accepted as 327 
policy-making tools that can inform resource allocation decisions. Almost half of the model-based 328 
studies chose a lifetime perspective and the vast majority of them applied Markov modelling.  329 
Most trial-based and model-based evaluations in this review applied recommended discount 330 
rates in accordance with the relevant country guidelines. Methods for collecting resource use and the 331 
type of cost included were found to vary across the studies. In particular, the indirect costs of 332 
overweight and obesity (e.g. productivity losses) were not generally collected alongside the trials. It 333 
is considered good practice to report results both with and without indirect costs. Including indirect 334 
costs (e.g. costs incurred by families) has the potential to alter the treatment recommendations.  335 
The narrative synthesis of the economic evidence and the quality assessment of the included 336 
studies are useful for informing health economists/modellers and the direction for future research in 337 
this area. In terms of judging cost-effectiveness of interventions, context-specific assessment is 338 
problematic as there are different thresholds for cost-effectiveness in different countries. For 339 
example, in the UK, NICE recommends a threshold willingness to pay of £20,000-£30,000 per QALY 340 
[64], by contrast in Australia the recommendation is AU$ 50,000 per QALY [30] and in many 341 
countries there are no clearly defined thresholds at all. Whilst most interventions in this review 342 
appear cost-effective using standard rules of cost-effectiveness, there is substantial variation by 343 
intervention design.  344 
4.1. Comparison with Previous Systematic Reviews  345 
Our finding that most interventions were cost-effective or even cost-saving, is similar to those 346 
reported by two other reviews [14, 20], with some overlap between included studies. Other reviews 347 
have focused on particular age groups (e.g. pre-schoolers [13]), specific interventions (e.g. only 348 
physical activity [17]), or particular outcomes (e.g. anthropometric measurements [13]). Two 349 
additional reviews from Australia [12] and the US [15] used the Assessing Cost-Effectiveness (ACE) 350 
obesity approach to summarise and compare the cost-effectiveness of a range of interventions. 351 
However, none of the previous studies reviewed the methods of the economic evaluations in the 352 
way we have outlined.  353 
4.2. Strengths and Limitations of this Review 354 
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One of the important strengths of this review is the comprehensive search strategy applied 355 
encompassing a broad range of electronic bibliographic databases of published studies and the grey 356 
literature (six additional studies were identified). Furthermore, the results were not limited to only 357 
those published in English (two non-English publications identified) and there were no country 358 
restrictions (there was one publication from china as a developing country), resulting in a more 359 
complete review than those published previously. Also, the formal quality assessment of the 360 
economic evaluations undertaken adds strength to the conclusions. The vast majority of the studies 361 
were found to be of very good reporting quality. 362 
The review had some limitations. As we focused on full economic evaluations, some important 363 
data contained within partial evaluations may have been missed. Further limitations relate to the 364 
shortcomings of the included studies and underlying evidence base. There was heterogeneity in 365 
both the methods used and with the type of intervention being evaluated, which made synthesising 366 
the evidence base challenging. Not all included studies used the same definition of obesity, which 367 
may impact on the results. Most of the included studies reported an economic evaluation for an 368 
intervention that had previously been reported as clinically effective. It is possible that any trial 369 
which had ineffective results did not conduct an economic evaluation or, if they did, failed to get it 370 
published, introducing potential publication bias.   371 
5. Conclusions 372 
This systematic review suggests that current economic evaluations are mainly set in developed 373 
countries and the majority focus on the prevention of obesity in children, compared to treatment. 374 
Our findings show that the majority of published economic evaluations are for interventions with an 375 
individual behaviour change component. The majority, particularly “behavioural and policy” 376 
preventive interventions, were cost-effective, even cost-saving. However the review found 377 
heterogeneity with respect to methods applied. So, to improve the evidence base further and to 378 
enhance comparability across interventions, we recommend a consistent and expanded form of 379 
economic evaluation which captures both health and non-health costs and consequences beyond 380 
health-gain. 381 
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